Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Forum
  • Discovery
  • About Us
    • Our Coverage
    • Team

Initiator Pharma

3.39 SEK

-0.59 %

Less than 1K followers

INIT

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Initiator Pharma

2019202020212022202320242025
Revenue
growth-%
EBITDA-13.0-14.2-31.8-62.7-40.4-22.3-
EBIT-13.1-14.3-31.8-62.7-40.4-22.3-25.7
Profit before taxes-14.0-13.9-33.4-66.3-41.4-22.8-24.1
Net income-11.6-11.8-29.0-57.8-34.2-19.9-19.8
EPS-0.46-0.40-0.66-1.10-0.66-0.35-0.29
Dividend0.000.000.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%
EBIT-%
ROE-83.6 %-60.4 %-60.2 %-113.1 %-204.9 %-87.5 %-46.3 %
ROI-72.5 %-55.7 %-39.2 %-81.0 %-76.8 %-84.6 %-41.5 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.